| Metric | Value ($ M) | Q2 FY25 | Q3 FY24 |
|---|---|---|---|
| Revenue | 150.46 | 1.1% | 5.3% |
| Total Income | 150.46 | 1.1% | 5.3% |
| Expenditure | 653.30 | 0.3% | 1.8% |
| PBT | 65.24 | 64.5% | 33.8% |
| Net Profit | -117.12 | 469.8% | 236.4% |
| OPM | — | ||
| NPM | -77.84% | 99.12pp | 137.96pp |
| EPS | -0.17 | 440.0% | 241.7% |
Healthpeak Properties Reports Q3 2025 Results
04 May 2026 · 4 May, 8:50 am
Summary
Healthpeak Properties announced its third quarter 2025 financial results, reporting a net loss of $(0.17) per share. The company's Merger-Combined Same-Store Cash (Adjusted) NOI grew by 0.9%. New and renewal lease executions totaled 1.5 million square feet. Healthpeak reaffirmed its full year 2025 guidance for diluted Nareit FFO per share of $1.78 – $1.84 and updated its guidance range for full year 2025 diluted earnings per common share from $0.25 – $0.31 to $0.00 – $0.06.
Key Highlights
- 1
Healthpeak Properties reported a total Merger-Combined Same-Store Cash (Adjusted) NOI growth of 0.9% for the third quarter of 2025.
- 2
Third quarter new and renewal lease executions totaled 1.5 million square feet, including 1.2 million square feet in Outpatient Medical.
- 3
CCRC Merger-Combined Same-Store Cash (Adjusted) NOI growth was 9.4% for the third quarter and 11.3% year-to-date.
- 4
Year-to-date non-refundable entry fee cash collections for CCRC totaled $108 million, a 13% increase compared to the same period last year.
- 5
Healthpeak issued $500 million of 4.75% senior unsecured notes due 2033 in August 2025.
- 6
As of October 23, 2025, Healthpeak had approximately $2.7 billion in available liquidity.
- 7
The company reaffirmed its full year 2025 guidance for diluted Nareit FFO per share of $1.78 – $1.84.
Informational and educational content only. Not investment advice.